Internal Medicine, Hepatology · Newton, MA
NPI
1922078930
Since 2006
Specialty
Internal Medicine, Hepatology
Code 207RI0008X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
2000 Washington St, Green Building, Suite 368
Newton, MA, 02462
Phone (617) 969-1227
Groups this clinician bills Medicare through
Medicare paid, 2024
$392K
11,839 services
Medicare patients, 2024
941
Average age 75
Drug cost, 2024
$1.7M
1,753 prescriptions
Company payments, 2025
$204
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Laurence S Bailen was code 99214 (office e&m - established), 423 times for 315 patients. In total Laurence S Bailen billed 11,839 services in 67 codes, and Medicare paid $392K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 423 | 315 | $102.42 | $43K |
| 45385 Colonoscopy - Lesion Removal | Facility | 223 | 221 | $214.58 | $48K |
| 43239 Upper GI Endoscopy | Facility | 157 | 149 | $79.63 | $13K |
| 45380 Lower GI Endoscopy - Other | Facility | 115 | 115 | $116.77 | $13K |
| 99204 Office E&M - New | Office | 98 | 98 | $136.47 | $13K |
| 99222 Hospital E&M - Initial | Facility | 83 | 81 | $105.35 | $8,744 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 55 | 55 | $188.23 | $10K |
| 45378 Lower GI Endoscopy - Other | Facility | 49 | 49 | $154.73 | $7,582 |
| 43249 Upper GI Endoscopy | Facility | 34 | 27 | $93.35 | $3,174 |
| 99232 Hospital E&M - Subsequent | Facility | 28 | 25 | $64.71 | $1,812 |
| 43235 Upper GI Endoscopy | Facility | 26 | 26 | $88.90 | $2,311 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 22 | 21 | $13.82 | $304 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 22 | 22 | $191.76 | $4,219 |
| 45385 Colonoscopy - Lesion Removal | Office | 15 | 15 | $327.93 | $4,919 |
| 43274 Upper GI Endoscopy | Facility | 13 | 12 | $381.35 | $4,958 |
By year: 2022 $316K for 9,239 services; 2023 $303K for 7,892 services; 2024 $392K for 11,839 services.
Medicare prescription drug claims, 2024
In 2024, the drug Laurence S Bailen prescribed most often to Medicare patients was Omeprazole, with 258 prescriptions and refills. In total Laurence S Bailen wrote 1,753 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 258 | 669 | 88 | $5,201 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 201 | 201 | 201 | $13K |
| Pantoprazole Sodium Generic | 112 | 283 | 34 | $1,801 |
| Linzess Linaclotide | 85 | 97 | 14 | $52K |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 83 | 83 | 38 | $1,453 |
| Sodium Chloride 0.9 % Sodium Chloride | 65 | 65 | Under 11 | $2,062 |
| Mesalamine Er Mesalamine | 65 | 91 | Under 11 | $22K |
| Clenpiq Sod Picosulf/Mag Ox/Citric Ac | 62 | 62 | 17 | $11K |
| Budesonide Ec Budesonide | 60 | 143 | 21 | $41K |
| Creon Lipase/Protease/Amylase | 58 | 73 | 12 | $83K |
| Famotidine Generic | 53 | 127 | 18 | $857 |
| Colestipol Hcl Generic | 50 | 90 | 18 | $6,002 |
| Budesonide Dr Budesonide | 45 | 74 | Under 11 | $3,312 |
| Stelara Ustekinumab | 39 | 69 | Under 11 | $1.1M |
| Dicyclomine Hcl Generic | 38 | 75 | 17 | $1,300 |
Brand drugs: - claims; generic drugs: 1,243 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Laurence S Bailen $204 ($204 in general payments such as food, travel and fees) from 2 companies. The largest payer was Gilead Sciences, Inc. with $180.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.